What Are GH Secretagogues?
GH secretagogues stimulate signaling pathways that can increase the body’s own growth-hormone release. CJC-1295 acts as a GHRH analog, while Ipamorelin and GHRP-6 activate the ghrelin receptor.
The GH–IGF-1 Axis
Hypothalamus
GHRH stimulates GH release; somatostatin inhibits it.
Pituitary
Growth hormone is released in pulses, especially during early-night sleep.
Liver
GH stimulates IGF-1 production.
Tissues
Muscle, bone, skin, and adipose tissue respond through multiple pathways.
Sponsored / AffiliateMomentous · Performance nutrition and recovery supplementsThree GH Secretagogues
CJC-1295
A synthetic GHRH analog. The DAC form has prolonged exposure.
Ipamorelin
Can provoke a short-acting GH pulse.
GHRP-6
Can increase GH release and strongly stimulate appetite.
Full Comparison
| Parameter | CJC-1295 | Ipamorelin | GHRP-6 |
|---|---|---|---|
| Class | GHRH analog | Ghrelin-receptor agonist | Ghrelin-receptor agonist |
| Exposure | Longer with DAC form | Short acting | Short acting |
| Main effect | Raises GH and IGF-1 | Provokes GH pulse | GH pulse and appetite |
| Human evidence | Early pharmacology | Limited | Limited |
| Appetite effect | Usually not primary | Often modest | Frequently pronounced |
| Approved for anti-aging or sports use | No | No | No |
| Long-term safety | Insufficient | Insufficient | Insufficient |
Sponsored / AffiliateApollo Peptide Sciences · Research-focused peptide science and molecular dataWhy Online “Stacks” Are Risky
CJC-1295 + Ipamorelin
Claim: stronger GH pulses with fewer adverse effects.
Reality: synergy is plausible, but long-term safety data are inadequate.
Secretagogues + BPC-157
Claim: faster tissue healing.
Reality: BPC-157 remains experimental.
Secretagogues + “Anti-Aging” Peptides
Claim: GH support plus geroprotection.
Reality: no validated longevity protocol exists.
Secretagogues + Fasting
Claim: low insulin maximizes fat loss.
Reality: short-term hormonal changes do not prove superior fat loss.
Safety and Contraindications
Clinical Safety Principles
- Confirm a genuine endocrine indication
- Use regulated products only where legally approved
- Review glucose control, sleep apnea, thyroid status, and cardiovascular risk
- Monitor under qualified supervision
- Do not combine multiple unapproved peptides
Seek Specialist Guidance
- Active or recent cancer
- Acromegaly or elevated GH / IGF-1 disorders
- Uncontrolled diabetes or significant insulin resistance
- Untreated sleep apnea
- Pregnancy or breastfeeding
- Severe cardiovascular, liver, or kidney disease
Two Common Myths
Myth: CJC plus Ipamorelin is the same as growth hormone, only safer.
Fact: They are different interventions, but “different” does not mean proven safe.
Myth: More secretagogue always creates a better GH response.
Fact: Receptor responses can plateau while adverse effects and cost continue to rise.
Frequently Asked Questions
Is CJC-1295 approved for anti-aging?
No.
Is Ipamorelin safer than older GHRPs?
It may be more selective pharmacologically, but long-term safety is not established.
Why does GHRP-6 increase appetite?
It activates ghrelin-related pathways involved in hunger signaling.
Does a higher IGF-1 level mean better health?
No. Higher is not automatically better.
Key Takeaways
- CJC-1295 is a GHRH analog.
- Ipamorelin and GHRP-6 act through the ghrelin receptor.
- Evidence for anti-aging, fat loss, recovery, and muscle gain is limited.
- Long-term safety and product quality are major concerns.
- There is no validated consumer peptide stack.
- Endocrine diagnosis and medical supervision matter more than timing.